Details of Drug

Drug General Information (ID: D0221)
Drug Name	Burosumab
Drug Type	Monoclonal antibody
Drug Synonymous	Burosumab [USAN]; UNII-G9WJT6RD29; G9WJT6RD29 Click to Show/Hide
Disease Class	5C63: Vitamin/non-protein cofactor absorption/transport disorder
Therapeutic Class	Metabolic Agents
External Link
External Link	TTD ID	D0DJ9D

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM006 Pharmacodynamic additive effects BM063 Increased risk of hypocalcemia BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Burosumab
Pharmacodynamic additive effects
	Increased risk of hypocalcemia					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0338		Cinacalcet	C22H22F3N	156419	Moderate		Inter Info	[2]
D0615		Etelcalcetide	C38H73N21O10S2	71511839	Moderate		Inter Info	[2]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 10
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0233		Calcifediol	C27H44O2	5283731	Major		Inter Info	[1]
D0234		Calcitriol	C27H44O3	5280453	Major		Inter Info	[1]
D0242		Calcium glycerophosphate	C3H7CaO6P	120096	Major		Inter Info	[1]
D0244		Calcium Phosphate	Ca3O8P2	24456	Major		Inter Info	[1]
D0495		Dihydrotachysterol	C28H46O	5311071	Major		Inter Info	[1]
D0527		Doxercalciferol	C28H44O2	5281107	Major		Inter Info	[1]
D1086		Monopotassium phosphate	H2KO4P	516951	Major		Inter Info	[1]
D1226		Paricalcitol	C27H44O3	5281104	Major		Inter Info	[1]
D1481		Sodium cellulose phosphate	NA	NA	Major		Inter Info	[1]
D1486		Sodium phosphate, monobasic	NA	NA	Major		Inter Info	[1]

References
1	Product Information. Crysvita (burosumab). Ultragenyx Pharmaceutical, Novato, CA.
2	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".